AI’s Approaches to Maternal and Neonatal Health in Low Resource Settings

By Sumona Bose

December 23, 2023

Introduction

A significant challenge faced by hospitals and medical practitioners in low- and middle-income countries is the lack of sufficient healthcare facilities for timely medical diagnosis of chronic and deadly diseases. Maternal and neonatal morbidity due to non-communicable and nutrition-related diseases is a serious public health issue that leads to several deaths every year. Detecting these conditions at their early stages is challenging, putting patients at risk of developing severe conditions over time. However, the advent of Artificial Intelligence (AI) has opened up new possibilities for improving maternal and neonatal health. This article will give an overview on AI’s Approaches to Maternal and Neonatal Health in Low Resource Settings.

AI holds Promise for Maternal and Neonatal Health

AI has emerged as a practical assistive tool in various healthcare sectors, but its application in maternal and neonatal health is still in its nascent stages. One example of how AI can be used in low-resource settings is in maternal health and diagnostics services. In these settings, access to proper healthcare infrastructure and professionals is limited, making it difficult to provide holistic care to pregnant women and their children. However, AI technologies such as digital chatbots and support groups can aid in maternal and neonatal health monitoring and management. These technologies can engage users in follow-up questions about their health in their desired language, helping to disperse basic health information.

Figure 1: Focus Areas on Role of AI in complimenting maternal health

 

Challenges and Solutions for AI

Explainable Artificial Intelligence (XAI) or Dependable AI (DAI) can provide insights into the decision-making process of AI models. This level of explainability increases the confidence that medical practitioners and AI researchers have in the system, leading to broader adoption of AI in the healthcare field. By understanding why someone has been classified as ill or otherwise, the perception of AI models as a “black box” can be changed, making them more scalable and employable. XAI can be merged with smart healthcare systems that incorporate the Internet of Things, cloud computing, and AI, particularly in the fields of maternal and neonatal health. These intelligent healthcare systems can be utilized for various purposes, including disease diagnosis and treatment selection.

In some crucial small sample size healthcare problems where large datasets are not available, Few-shot learning or Zero-shot learning can be used to train AI models. These learning frameworks utilize domain information to reach medical decisions or predictions, making them efficient tools for doctors to handle rare medical conditions and problems that require years of experience.

Conclusion

Improving maternal and newborn health requires bringing speedy diagnosis and treatment to point-of-care settings in developing nations with limited resources.

Reference url

Recent Posts

HIV prevention injection
   

FDA Approval and Access Strategy for Lenacapavir (Yeztugo) Long-Acting HIV Prevention

🌍 Will Yeztugo Approval and Access Strategy Deliver an Inflection Point in HIV/AIDS?

Yeztugo (lenacapavir), a twice-yearly injection, redefines long-acting HIV prevention with 96–100% efficacy. Gilead’s access strategy—insurance, assistance, and generics for 120 countries—targets global impact. Can it balance $28,218 U.S. costs with equity for 1.3M annual infections? My article explores health economics, public health, and market dynamics.

📖 Read how Yeztugo’s access strategy could transform long-acting HIV prevention

#SyenzaNews #GlobalHealth #HIVPrevention #Yeztugo #PrEP

essential prescription drugs
       

Canada Launches Consultation for Essential Prescription Drugs List

💊 Are you curious about how Canada plans to make essential prescription drugs accessible for everyone?

Canada’s Drug Agency has launched a national consultation to create a list of essential prescriptions that aim to ensure equitable access, improve health outcomes, and reduce costs. This initiative marks a key step towards universal pharmacare and highlights the importance of evidence-based practices in healthcare.

Dive into our latest article to learn more about the implications for patients, policymakers, and the broader healthcare system!

#SyenzaNews #healthcare #HealthEconomics

ACIP vaccine policy concerns
     

ACIP Vaccine Policy Concerns

🛑 Is the future of vaccine policy at risk?

The recent overhaul of the US Advisory Committee on Immunization Practices (ACIP) raises critical concerns about the integrity and transparency in vaccine recommendations. The abrupt removal of longstanding members may disrupt the essential processes that have historically upheld public trust and immunization success.

Curious about the implications for health policy and public health? Dive into the full analysis to understand the balance needed between continuity and reform!

#SyenzaNews #HealthcarePolicy #HealthEconomics #Innovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.